Clinisindo Putra Perkasa is primarily engaged in pharmaceuticals, mail order activity. Its headquarters is located in Dki Jakarta. The company was founded in 1997. Clinisindo Putra Perkasa is a prominent player in the Indonesian pharmaceutical industry, focusing on the distribution and mail order of pharmaceutical products. The company was founded by a group of visionary entrepreneurs who aimed to enhance the accessibility of healthcare products across Indonesia. The primary business line of Clinisindo Putra Perkasa is the distribution of pharmaceutical products, while its secondary business line includes mail order services, which allow customers to conveniently order medications and health products online. The company has established a strong local geographical footprint with several branches across major cities in Indonesia, ensuring efficient distribution and customer service. Clinisindo Putra Perkasa offers a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. The company is known for its commitment to quality and reliability, partnering with reputable pharmaceutical manufacturers to ensure the authenticity and safety of its products. While the company primarily operates within Indonesia, it has ambitions to expand its reach to neighboring Southeast Asian markets. Clinisindo Putra Perkasa is a member of several industry associations, which helps it stay updated with the latest industry trends and regulations. The company is dedicated to improving healthcare accessibility and aims to become a leading pharmaceutical distributor in the region. Its mission is to provide high-quality healthcare products and services that enhance the well-being of its customers.
Headquarters
RT 009 RW 003
West Jakarta; Jakarta;
Postal Code: 11630
Contact Details: Purchase the PT Clinisindo Putra Perkasa report to view the information.
Website: http://www.medicastore.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service